Aston Medical School is looking for an Early Stage Researcher (ESR) to work on the project “Enhancing imaging of the placenta in murine models of preeclampsia and standardisation of preeclampsia mouse models (ESR11)” as part of iPLACENTA network collaborating with 14 other ESRs based in 11 European academic, industrial and clinical institutes.
The Cancer Research UK Beatson Institute in Glasgow is one of the world leading centres for cancer research. The Institute provides an outstanding research environment, underpinned by state-of-the-art core services and advanced technologies with special emphasis on imaging, metabolomics and in vivo models of cancer.
Sepsis is a major health care burden with unacceptably high rates of mortality. The underlying pathogenic mechanisms are multifactorial involving dysfunctional immune and metabolic responses to infection.
Despite major advances in imaging technologies, surgery, chemotherapy, radiotherapy and targeted therapy of cancer in the last few decades, pancreatic cancer remains as one of the most aggressive and fatal types of human cancer.
The projection that within 50 years there will be more deaths from antimicrobial resistance than through cancer highlights the continual need for mining new and novel antimicrobials with activity against planktonic microbes and biofilms alike1.
Cervical cancer is one of the most common types of cancer affecting women worldwide. Infection caused by high-risk human papillomaviruses (HPVs), especially type 16 and 18 are implicated in the etiology of most cervical cancers.
The SPARC family of matricellular proteins determine the way in which cells respond to their extracellular environment. SPARC family proteins interact with a range of binding partners, including matrix proteins (1).